Size | Price | Stock | Qty |
---|---|---|---|
100mg |
|
||
250mg |
|
||
500mg |
|
||
1g |
|
||
2g |
|
||
5g |
|
||
10g |
|
||
Other Sizes |
|
ln Vitro |
Strong anticoagulant heparin speeds up the rate at which antiphospholipase prevents the staining of silk dye in an uneven series of reactions. Peptides with complementary binding sites and a high positive charge density elicit a strong reaction from heparin. Heparin and DNA are both highly charged linear polymers that exhibit polyelectrolyte behavior. As heparin binds to the complex AT III and delta enzyme in the ternary complex, increasing the AT-III-mediated response to factor Xa, including factor enzymes, the concentration of the molecular solution increases 2000 times. This is the primary mechanism by which heparin is thought to act in response to AT III. Heparin is mostly found in tissues connected to immunological responses in mast cell granules. To stabilize FGF-FGFR binding, heparin interacts with FGFR-1 and FGF-2 many times. Heparin appears to encourage FGFR dimerization since it also interacts with FGFR-1 of the nearby FGF-FGFR complex [1].
|
---|---|
References |
[1]. Capila I, et al. Heparin-protein interactions. Angew Chem Int Ed Engl. 2002 Feb 1;41(3):391-412.
[2]. Anurag Purushothaman, et al. Fibronectin on the Surface of Myeloma Cell-derived Exosomes Mediates Exosome-Cell Interactions. J Biol Chem. 2016 Jan 22;291(4):1652-63. |
Molecular Formula |
C9H8O2
|
---|---|
Molecular Weight |
148.15862
|
CAS # |
9045-22-1
|
Related CAS # |
Heparin sodium salt;9041-08-1;Heparin sodium salt (MW 15kDa);9041-08-1;Heparin;9005-49-6
|
SMILES |
O[C@H]1[C@H](O[C@H]2[C@H](OS(O)(=O)=O)[C@@H](O)[C@H](OC)[C@H](C(O)=O)O2)[C@@H](COS(O)(=O)=O)O[C@H](OC)[C@@H]1NS(O)(=O)=O.[n].[.xLi]
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
H2O : ~100 mg/mL
|
---|---|
Solubility (In Vivo) |
Solubility in Formulation 1: 100 mg/mL (Infinity mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.
 (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 6.7495 mL | 33.7473 mL | 67.4946 mL | |
5 mM | 1.3499 mL | 6.7495 mL | 13.4989 mL | |
10 mM | 0.6749 mL | 3.3747 mL | 6.7495 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.